In addition to several large European and Czech scientific infrastructures, the National Institute for Cancer Research will also cooperate with various university hospitals, pharmaceutic or biotechnological companies, patient organisations, and other partners.

Large research infrastructures

Research teams of the National Institute for Cancer Research intensively used the infrastructure included in the Roadmap of Large Research Infrastructures (ESFRI).

Clinical institutions – oncological centres providing comprehensive care

Research teams of the National Institute for Cancer Research cooperate with Comprehensive Cancer Centres.
  • Motol University Hospital, Prague
  • General University Hospital in Prague
  • Central Military Hospital – Military University Hospital Prague
  • University Hospital Brno
  • University Hospital Olomouc
  • University Hospital Ostrava

Other partners

  • Institute of Health Information and Statistics of the Czech Republic
  • Cluster of Medicinal Chemistry and Chemical Biology MedChemBio
  • Cancer Research Foundation, Czech Republic
  • BioVendor – Laboratory Medicine, Plc.
  • IntellMed, Ltd.
  • Institute of Applied Biotechnologies, Plc
  • oncomed manufacturing, Plc
  • CGB Laboratory, Ltd.